Merck & Co. MRK Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $16.29B+4.9% | $16.4B+5.0% | $17.28B+3.7% | $15.81B-1.9% | $15.53B-1.6% | ||
| $4.2B+22.7% | $5.55B+45.0% | $3.86B-5.5% | $3.56B-5.0% | $3.42B-3.4% | ||
| $12.09B-0.2% | $10.85B-8.0% | $13.42B+6.7% | $12.25B-1.0% | $12.11B-1.0% | ||
| 74.2%-3.7pp | 66.2%-9.3pp | 77.7%+2.2pp | 77.5%+0.7pp | 78%+0.4pp | ||
| $12.59B+248% | $3.89B-15.2% | $4.23B-27.8% | $4.05B+15.7% | $3.62B-9.3% | ||
| $2.7B+5.8% | $2.9B+1.2% | $2.63B-3.6% | $2.65B-3.3% | $2.55B+2.8% | ||
| $195M+183% | $213M+318% | $47M-16.1% | $560M+600% | $69M-43.9% | ||
| -$3.53B-160% | $3.42B-18.0% | $6.75B+64.9% | $5B-16.8% | $5.9B+4.1% | ||
| $709M-13.3% | $458M+7.5% | $958M+3.1% | $571M+4.8% | $818M-9.4% | ||
| -$4.24B-183% | $2.96B-20.8% | $5.79B+83.2% | $4.43B-18.8% | $5.08B+6.7% | ||
| -26%-58.7pp | 18.1%-5.9pp | 33.5%+14.5pp | 28%-5.8pp | 32.7%+2.5pp | ||
| -$1.72-186% | $1.20-18.9% | $2.32+87.1% | $1.76-17.8% | $2.01+7.5% | ||
| -$1.72-186% | $1.21-18.2% | $2.32+85.6% | $1.76-18.1% | $2.01+6.9% | ||
| $19.82B+106% | $12.98B+13.3% | $10.53B-16.2% | $10.81B+6.9% | $9.63B-4.7% | ||
| -$138M-494% | -$432M— | $238M+46.9% | $7M+117% | $35M+6.1% | ||
| -$2.95B-146% | $4.91B+4.7% | $7.28B+56.7% | $5.52B-15.4% | $6.41B+3.6% | ||
| -18.1%-59.4pp | 30%-0.1pp | 42.1%+14.2pp | 34.9%-5.6pp | 41.2%+2.1pp | ||
| -$3.53B-160% | $3.42B-18.0% | $6.75B+64.9% | $5B-16.8% | $5.9B+4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Merck & Co.'s revenue?
- Merck & Co. (MRK) generated $65.8B in revenue over the trailing twelve months, up 2.9% year over year.
- Is Merck & Co. profitable?
- Merck & Co. reported $8.9B in net income over the trailing twelve months, a 13.6% net margin.
- What is Merck & Co.'s earnings per share?
- Merck & Co.'s diluted EPS over the trailing twelve months is $3.56.
- Where does Merck & Co.'s income statement data come from?
- Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
